Sales and Marketing

By Dr. Richard Graham Industry conversations about clinical trial participation tend to focus on awareness, access, and willingness to enrol. …

Advances in computed tomography (CT) technology are helping to reshape the diagnosis and management of chronic respiratory disease, with new …

Cambridge Wide Open Week (CWOW) returns from 11-19 June 2026, sharing the spirit and buzz of the week-long, interactive festival …

SAH Diagnostics has opened a new privately run diagnostics centre in Bradley Stoke, Bristol, aiming to speed up cancer treatments …

Alto Neuroscience, a clinical-stage biopharmaceutical company specialising in precision treatments for neuropsychiatric conditions, has announced the issuance of a US …

Arkin Capital has announced the closing of Arkin Bio Ventures III, a $100m fund designed to invest in pre-clinical and …

PSI, a global contract research organisation (CRO), has announced the opening of a new office in Osaka as part of …

Andera Partners, a private equity firm, has announced its leadership of a $67m series A financing round in Spiro Medical, …

The Export and Investment Fund of Denmark (EIFO) and Fåhraeus Startup and Growth Fund (FSG) have invested 5m euros in …

Samsung Bioepis has announced the European launch of Obodence and Xbryk, two new denosumab biosimilars approved for the treatment of …

Sandoz has announced the European launch of two new bone disease biosimilars. Wyost (denosumab 120 mg) is approved for the …

Gilead has announced the first shipments of its HIV prevention drug lenacapavir to Eswatini and Zambia, a milestone in the …

Cellbyte has announced that it has raised $2.75m in seed funding for the streamlining of pharmaceutical drug launches. The complexity …

By Sabina Syed, Managing Director at Visions4Health In the history of science, few initiatives demonstrate the magnitude of coordinated effort …

In the sixth of the Gateway to Local Adoption series, Visions4Health’s Head of Client Services, Jonny Savage, shares his views …